Active Biotech AB | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
145.24 M |
Public Float |
- |
Active Biotech AB | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK0.25 |
Market Cap |
SEK446.6 M |
Shares Outstanding |
145.24 M |
Public Float |
86.64 M |
Address |
Scheelevägen 22 Lund SN 223 63 Sweden |
Employees | - |
Website | http://www.activebiotech.com |
Updated | 07/08/2019 |
Active Biotech AB develops pharmaceutical preparations. It develops pharmaceutical products within medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease and various forms of cancer. The company's project portfolio comprises small, orally active immunomodulatory molecules as well as antibody-based immunotherapy. |